Abbott Laboratories (NYSE:ABT) received an upgrade by equity research analysts at Jefferies & Co Monday morning from Hold to Buy.…
Abbott Laboratories (NYSE:ABT) received an upgrade by equity research analysts at Jefferies & Co Monday morning from Hold to Buy.…
BMO Capital Markets has lowered the price target for Abbot Laboratories (NYSE:ABT) to US$48.00 from US$56.00 a share before Monday’s…